SFM
Sphera Funds Management Portfolio holdings
AUM
$581M
1-Year Est. Return
112.94%
This Fund
S&P 500
1 Year Est. Return
+112.94%
AUM
$581M
AUM Growth
+$103M
(+22%)
Holding
117
Top Buys
| 1 | +$26.1M | |
| 2 | +$11.5M | |
| 3 | +$9.97M | |
| 4 |
Cellebrite
CLBT
|
+$9.52M |
| 5 |
Palo Alto Networks
PANW
|
+$8.87M |
Top Sells
| 1 | +$11.8M | |
| 2 | +$6.61M | |
| 3 | +$5.4M | |
| 4 |
Oric Pharmaceuticals
ORIC
|
+$5.3M |
| 5 |
ATXS
Astria Therapeutics
ATXS
|
+$4.66M |
Sector Composition
| 1 | Healthcare | 80.2% |
| 2 | Technology | 15.28% |
| 3 | Utilities | 1.31% |
| 4 | Consumer Discretionary | 1.14% |
| 5 | Industrials | 0.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Immatics
IMTX
$1.38B
| $6.85M | 1.18% |
696,105
-165,000
|
|
||
27
Trevi Therapeutics
TRVI
$1.93B
| $6.85M | 1.18% |
574,029
-24,505
|
|
||
|
28
Oric Pharmaceuticals
ORIC
$770M
| $6.81M | 1.17% |
537,628
-466,750
|
|
||
|
MAZE
29
Maze Therapeutics
MAZE
$1.35B
| $6.79M | 1.17% |
227,343
+155,500
|
|
||
30
GSK
GSK
$98B
| $6.73M | 1.16% |
122,000
|
|
||
31
Amazon
AMZN
$2.78T
| $6.65M | 1.14% |
+31,940
|
|
||
32
AbbVie
ABBV
$378B
| $6.58M | 1.13% |
30,256
+5,000
|
|
||
33
Applied Optoelectronics
AAOI
$15.9B
| $6.21M | 1.07% |
+73,400
|
|
||
34
Enliven Therapeutics
ELVN
$2.19B
| $6.01M | 1.03% |
153,265
-73,500
|
|
||
35
Merck
MRK
$286B
| $5.85M | 1.01% |
48,600
|
|
||
36
Vor Biopharma
VOR
$756M
| $5.74M | 0.99% |
321,917
-88,500
|
|
||
37
Acadia Pharmaceuticals
ACAD
$3.56B
| $5.7M | 0.98% |
256,202
+44,000
|
|
||
38
Novartis
NVS
$273B
| $5.65M | 0.97% |
37,000
|
|
||
39
Eledon Pharmaceuticals
ELDN
$275M
| $5.46M | 0.94% |
1,772,131
-360,000
|
|
||
40
Enphase Energy
ENPH
$9.19B
| $5.38M | 0.93% |
142,419
-44,081
|
|
||
41
Revolution Medicines
RVMD
$32.3B
| $5.36M | 0.92% |
55,110
+2,610
|
|
||
42
Pfizer
PFE
$146B
| $5.22M | 0.9% |
186,000
+100,000
|
|
||
43
Biohaven
BHVN
$1.56B
| $5.03M | 0.86% |
+594,000
|
|
||
44
Forte Biosciences
FBRX
$361M
| $4.79M | 0.82% |
184,984
-885
|
|
||
|
HELP
45
Cybin Inc
HELP
$229M
| $4.74M | 0.81% |
987,090
+161,514
|
|
||
46
Madrigal Pharmaceuticals
MDGL
$10.6B
| $4.73M | 0.81% |
9,040
+5,740
|
|
||
47
Scholar Rock
SRRK
$5.43B
| $4.63M | 0.8% |
94,265
-64,000
|
|
||
|
NVO
48
Novo Nordisk
NVO
$190B
| $4.43M | 0.76% |
120,677
+5,000
|
|
||
49
MediWound
MDWD
$177M
| $4.4M | 0.76% |
273,192
+42,845
|
|
||
50
Kodiak Sciences
KOD
$2.15B
| $4.38M | 0.75% |
114,796
-60,704
|
|